Samer of Zaky

Dr. Samer of Zaky

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Acta Biomaterialia
Verified
Journal Article
Closed access
ABAndrew Brown
Andrew Brown
Samer of ZakySamer of Zaky
Samer of Zaky
HRHerbert Ray
Herbert Ray
CSCharles Sfeir
Charles Sfeir

17 October 2008 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
Samer of ZakySamer of Zaky
Samer of Zaky
AOA. Ottonello
A. Ottonello
PSP. Strada
P. Strada
RCR. Cancedda
R. Cancedda
MMM. Mastrogiacomo
M. Mastrogiacomo
The heterogeneous population of non-haematopoietic cells residing in the bone marrow (bone marrow stromal cells, BMSCs) and the different fractions and components obtained from platelet-rich plasma provide an invaluable source of autologous cells and growth factors for bone and other connective tissue reconstruction. In this study, we investigated the effect of an allogenic platelet lysate on human BMSCs proliferation and differentiation. Cell proliferation and number of performed cell doublings were enhanced in cultures supplemented with the platelet-derived growth factors (platelet lysate, PL), either with or without the concomitant addition of fetal bovine serum (FBS), compared to cultures performed in the presence of FBS and FGF2. Both in vitro and in vivo osteogenic differentiation were unaltered in cells maintained in medium supplemented with PL and not FBS (Only PL) and in cells maintained in medium containing FBS and FGF2. Interestingly, the in vitro cartilage formation was more effective in the pellet of BMSCs expanded in the Only PL medium. In particular, a chondrogenic differentiation was observed in pellets of some in vitro-expanded BMSCs in the Only PL medium, whereas pellets from parallel cell cultures in medium containing FBS did not respond to the chondrogenic induction. We conclude that the platelet lysate from human source is an effective and even more beneficial substitute for fetal bovine serum to support the in vitro expansion of human BMSCs for subsequent tissue-engineering applications. Copyright © 2008 John Wiley & Sons, Ltd.

6 November 2009 in Journal of Dental Research
Verified
Journal Article
Closed access
PDF file
Samer of ZakySamer of Zaky
Samer of Zaky
RCR. Cancedda
R. Cancedda
The human innate regenerative ability is known to be limited by the intensity of the insult together with the availability of progenitor cells, which may cause certain irreparable damage. It is only recently that the paradigm of tissue engineering found its way to the treatment of irreversibly affected body structures with the challenge of reconstructing the lost part. In the current review, we underline recent trials that target engineering of human craniofacial structures, mainly bone, cartilage, and teeth. We analyze the applied engineering strategies relative to the selection of cell types to lay down a specific targeted tissue, together with their association with an escorting scaffold for a particular engineered site, and discuss their necessity to be sustained by growth factors. Challenges and expectations for facial skeletal engineering are discussed in the context of future treatment.

1 January 2013 in Tissue Engineering Part A
Verified
Journal Article
Closed access
RERania ElBackly
Rania ElBackly
Samer of ZakySamer of Zaky
Samer of Zaky
AMAnita Muraglia
Anita Muraglia
LTLaura Tonachini
Laura Tonachini
Francesco BrunFrancesco Brun
Francesco Brun
MMMaddalena Mastrogiacomo
Maddalena Mastrogiacomo
The periosteum plays a pivotal role during bone development and repair contributing to bone vascularization and osteoprogenitor cells source. We propose a periosteal substitute engineered using a platelet-rich plasma (PRP) membrane incorporating autologous bone marrow-derived mesenchymal stem cells (PRP/BMSC gel membrane) to be wrapped around an osteoconductive scaffold for regeneration of compromised bone defects. The PRP/BMSC gel membrane was optimized using different compositions for optimal release of vascular endothelial growth factor (VEGF) and platelet derived growth factor-BB (PDGF-BB). Survival and proliferation of cells in the PRP gel membrane with time were confirmed in addition to their osteogenic capacity. Furthermore, to evaluate the possible effects of the PRP/BMSC gel membrane on surrounding progenitor cells in the injury area, we found that the PRP gel membrane products could significantly induce the migration of human endothelial cells in vitro, and increased the expression of bone morphogenetic protein 2 in cultured BMSC. These cells also secreted significant amounts of soluble proangiogenic factors, such as PDGF-BB, VEGF, and interleukin-8 (IL-8). Finally, the functionality of the PRP/BMSC gel membrane periosteal substitute for bone regeneration was tested in vivo both in an ectopic mouse model as well as in a rabbit segmental bone defect model providing evidence of its capacity to biomimic a periosteal response enhancing bone regeneration.

1 January 2014 in Tissue Engineering Part A
Verified
Journal Article
Closed access
Samer of ZakySamer of Zaky
Samer of Zaky
KLKee-Won Lee
Kee-Won Lee
JGJin Gao
Jin Gao
AJAdrianna Jensen
Adrianna Jensen
JCJohn Close
John Close
CSCharles Sfeir
Charles Sfeir
The selection criteria for potential bone engineering scaffolds are based chiefly on their relative mechanical comparability to mature bone. In this study, we challenge this notion by obtaining full regeneration of a rabbit ulna critical size defect by employing the elastomeric polymer, poly(glycerol sebacate) (PGS). We tested the regeneration facilitated by PGS alone, PGS in combination with hydroxyapatite particles, or PGS seeded with bone marrow stromal cells. We investigated the quantity and quality of the regenerated bone histologically, by microcomputed tomography and by four-point bending flexural mechanical testing at 8 weeks postimplantation. We conclude that the relatively lower stiffness of this biocompatible elastomer allows a load-transducing milieu in which osteogenesis, matrix deposition, and eventual bone maturation can take place. This study's results suggest that PGS elastomer is an auspicious osteoconductive material for the regeneration of bony defects. These results call for an innovative reassessment of the current art of selection for novel bone scaffold materials.

1 July 2014 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
RERania ElBackly
Rania ElBackly
Samer of ZakySamer of Zaky
Samer of Zaky
BCBarbara Canciani
Barbara Canciani
MSManal M. Saad
Manal M. Saad
AEAhmed M. Eweida
Ahmed M. Eweida
RCRanieri Cancedda
Ranieri Cancedda